Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.

ABSTRACT:

Background

Differences in receipt of guideline-concordant treatment might underlie well-established racial disparities in endometrial cancer mortality.

Objective

Using the National Cancer Database, we assessed the hypothesis that among women with endometrioid endometrial cancer, racial/ethnic minority women would have lower odds of receiving guideline-concordant treatment than white women. In addition, we hypothesized that lack of guideline-concordant treatment was linked with worse survival.

Study design

We defined receipt of guideline-concordant treatment using the National Comprehensive Cancer Network guidelines. Multivariable logistic regression models were used to compute odds ratios and 95% confidence intervals for associations between race and guideline-concord

SUBMITTER: Kaspers M 

PROVIDER: S-EPMC7483220 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature